Pregabalin Capsule
Product Images NDC 82804-184

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 82804-184). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camberlogo (Camberlogo)

FDA Label Image

Pregabalinfigure1 (Pregabalinfigure1)

FDA Label Image

Pregabalinfigure10 (Pregabalinfigure10)

FDA Label Image

Pregabalinfigure11 (Pregabalinfigure11)

FDA Label Image

Pregabalinfigure12 (Pregabalinfigure12)

FDA Label Image

Pregabalinfigure2 (Pregabalinfigure2)

FDA Label Image

Pregabalinfigure3 (Pregabalinfigure3)

FDA Label Image

Pregabalinfigure4 (Pregabalinfigure4)

This text provides information on the percentage of patients who have shown improvement while taking different doses of Pregabalin and Placebo over a specific duration. The data is presented in a graphical format showing the percentage of improvement in pain from the baseline measurements.*

FDA Label Image

Pregabalinfigure5 (Pregabalinfigure5)

FDA Label Image

Pregabalinfigure6 (Pregabalinfigure6)

FDA Label Image

Pregabalinfigure7 (Pregabalinfigure7)

FDA Label Image

Pregabalinfigure8 (Pregabalinfigure8)

This text appears to provide data on responder rates for different dosages in a study. It shows responder rates of 22.6%, 29.1%, and 40.6% for different dosages compared to placebo. Dosages mentioned in the text are 2.5 mg/kg/day with 103 participants and 10 mg/kg/day with 96 participants.*

FDA Label Image

Pregabalinfigure9 (Pregabalinfigure9)

This data table shows the percentage of patients who experienced improvement in pain from baseline after different daily doses of Pregabalin and a placebo. The percentages are recorded for 600mg, 450mg, and 300mg daily doses of Pregabalin, as well as for the placebo group.*

FDA Label Image

Pregabalinstructure (Pregabalinstructure)

FDA Label Image

82804-184-30 (Pregablin Capsules 50 Container 60)

This is a medication information sheet for Pregabalin 50mg capsules, manufactured by HETERO™ Labs Limited in India. Each capsule contains 50 mg of Pregabalin and is white in color, imprinted with "139" on the cap and "J" on the body. The capsules are filled with white to off-white powder. The medication guide should be dispensed to each patient. Store the capsules at temperatures between 20°C to 25°C (68°F to 77°F) and keep them out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.